The use of Venetoclax in Chronic Lymphocytic Leukaemia
The use of venetoclax in chronic lymphocytic leukaemia – which patients are not suitable?
Prof John Seymour, Director of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
Prof John Seymour, Director of Haematology at Peter MacCallum Cancer Centre and Royal Melbourne Hospital discussed how venetoclax is used in chronic lymphocytic leukaemia.
He discusses why venetoclax may not be suitable for some patients.
For more information please visit the Lymphoma Australia website:
• Lymphoma Australia website: www.lymphoma.org.au
• Resources: https://www.lymphoma.org.au/page/1218/fact-sheets
• Lymphoma Resources:
o Lymphoma: what you need to know? (booklet)
o Living with CLL (booklet)
o Lymphoma subtypes – fact sheets
o Lymphoma Management
o Oral therapies and lymphoma/CLL
o Understanding clinical trials
o Supportive care
o Emotional impact of lymphoma
• “Lymphoma Down Under” private Facebook group; support for patients & carers affected by lymphoma/CLL
• Lymphoma Care Nurse Support Line:
• T: 1800 953 081
• E: nurse@lymphoma.org.au
No comments found